|
Irbesartan and Hydrochlorothiazide
|
|
Avalide
|
Irbesartan and Hydrochlorothiazide Clinical Trials
- Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
ClinicalTrials.gov Identifier: NCT00500604 - Recruiting
Hypertension
- Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
ClinicalTrials.gov Identifier: NCT00443612 - Recruiting
Hypertension
- Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension
ClinicalTrials.gov Identifier: NCT00263003 - Completed
Hypertension
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
ClinicalTrials.gov Identifier: NCT00095394 - Completed
Hypertension
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients with Moderate Hypertension
ClinicalTrials.gov Identifier: NCT00095550 - Completed
Hypertension
- Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
ClinicalTrials.gov Identifier: NCT00439738 - Active, not recruiting
Hypertension
- Irbesartan in the Treatment of Hypertensive Patients with Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00110422 - Completed
Metabolic Syndrome X; Hypertension
- Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
ClinicalTrials.gov Identifier: NCT00425997 - Active, not recruiting
Hypertension
- Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00387517 - Active, not recruiting
Hypertension
- Irbesartan in Heart Failure with Preserved Systolic Function (I-Preserve)
ClinicalTrials.gov Identifier: NCT00095238 - Active, not recruiting
Congestive Heart Failure
- Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00265642 - Recruiting
Hepatitis C, Chronic
- I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00335673 - Active, not recruiting
Hypertension
- Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients with Hypertension and Permanent Pacemakers
ClinicalTrials.gov Identifier: NCT00225667 - Not yet recruiting
Atrial Fibrillation; Hypertension
- A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension.
ClinicalTrials.gov Identifier: NCT00153049 - Completed
Hypertension
- Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00426478 - Active, not recruiting
Hypertension
- Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril
ClinicalTrials.gov Identifier: NCT00394394 - Completed
Hypertension
- A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison with Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients with Mild to Modera
ClinicalTrials.gov Identifier: NCT00133185 - Completed
Hypertension
- Safety and Efficacy of Valsartan Versus Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00396656 - Active, not recruiting
Hypertension
- Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria
ClinicalTrials.gov Identifier: NCT00334581 - Recruiting
Hypertension
- I PREVENT - Irbesartan In Hypertensive Diabetic Patients
ClinicalTrials.gov Identifier: NCT00362258 - Recruiting
Hypertension
- Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
ClinicalTrials.gov Identifier: NCT00282178 - Active, not recruiting
Hypertension; Obesity
- Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients with Hypercholesterolemia
ClinicalTrials.gov Identifier: NCT00152698 - Completed
Hypercholesterolemia
- I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
ClinicalTrials.gov Identifier: NCT00362037 - Recruiting
Hypertension
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE)
ClinicalTrials.gov Identifier: NCT00249795 - Active, not recruiting
Atrial Fibrillation; Cardiovascular Disease
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00277472 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00280540 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
ClinicalTrials.gov Identifier: NCT00400777 - Active, not recruiting
Hypertension
- A Clinical Study to Evaluate the Long-Term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg
ClinicalTrials.gov Identifier: NCT00171405 - Active, not recruiting
Hypertension
- A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients
ClinicalTrials.gov Identifier: NCT00219102 - Active, not recruiting
Hypertension; Diabetes
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
ClinicalTrials.gov Identifier: NCT00360178 - Completed
Hypertension
- Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
ClinicalTrials.gov Identifier: NCT00343551 - Active, not recruiting
Essential Hypertension
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE)
ClinicalTrials.gov Identifier: NCT00249873 - Active, not recruiting
Atrial Fibrillation; Vascular Risk
- Irbesartan in Hypertension
ClinicalTrials.gov Identifier: NCT00265967 - Active, not recruiting
Hypertension
- A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg [Micardis HCT] Versus Valsartan 160 Mg + Hydrochlorothiazide 25 Mg [Diovan HCT] Taken Orally for Eight Weeks in Patien
ClinicalTrials.gov Identifier: NCT00168779 - Completed
Hypertension
- Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
ClinicalTrials.gov Identifier: NCT00232882 - Recruiting
Hypertension
- Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
ClinicalTrials.gov Identifier: NCT00509470 - Recruiting
Essential Hypertension
- Irbesartan vs. Placebo in Combination with Ramipril for Treatment of Albuminuria
ClinicalTrials.gov Identifier: NCT00095290 - Completed
Albuminuria
- A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
ClinicalTrials.gov Identifier: NCT00386607 - Active, not recruiting
Hypertension
- A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00170937 - Active, not recruiting
Metabolic Syndrome; Hypertension; Pre-Hypertension
- Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
ClinicalTrials.gov Identifier: NCT00446563 - Active, not recruiting
Hypertension; Hypertrophy, Left Ventricular
- Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00548067 - Recruiting
Hypertension
- Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months
ClinicalTrials.gov Identifier: NCT00487123 - Recruiting
Hypertension
- Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
ClinicalTrials.gov Identifier: NCT00517322 - Recruiting
Left Atrial Volume; Hypertensive Heart Disease; Antihypertensive Drugs; Diastolic Function; Renin Angiotensin System
- The Vascular Effects of Carvedilol CR + Lisinopril Versus Lisinopril + Hydrochlorothiazide in Abdominally Obese Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00459056 - Recruiting
Abdominal Obesity; Hypertension
- Comparison of Vascular Effects After Therapy with Irbesartan and Atorvastatin.
ClinicalTrials.gov Identifier: NCT00154024 - Completed
Healthy subjects
- Losartan vs. Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects
ClinicalTrials.gov Identifier: NCT00388388 - Recruiting
Pre-Hypertension; Pre-Diabetes
- A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-Label, Blinded
ClinicalTrials.gov Identifier: NCT00240474 - Completed
Hypertension
- Hydrochlorothiazide (+) Losartan Potassium Vs. Amlodipine Comparative Study
ClinicalTrials.gov Identifier: NCT00157963 - Completed
Essential Hypertension
- Left Ventricular Function After AMI. Treatment with Angiotensin 2-Receptor Blockade (GLOBAL-Study)
ClinicalTrials.gov Identifier: NCT00125645 - Recruiting
Acute myocardial infarction (AMI)
- Open-Label Trial of the Efficacy and Safety of Combination of Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg Tablets in Patients With Hypertension.
ClinicalTrials.gov Identifier: NCT00267943 - Completed
Hypertension
- Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
ClinicalTrials.gov Identifier: NCT00139698 - Completed
Essential Hypertension
- Irbesartan and Atenolol in Hypertensive Heart Disease
ClinicalTrials.gov Identifier: NCT00389168 - Completed
Hypertension
- Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
ClinicalTrials.gov Identifier: NCT00430508 - Not yet recruiting
Essential Hypertension
- Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
ClinicalTrials.gov Identifier: NCT00430950 - Not yet recruiting
Essential Hypertension
- Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions
ClinicalTrials.gov Identifier: NCT00350038 - Completed
Hypertension; Dyslipidemia
- Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)
ClinicalTrials.gov Identifier: NCT00263393 - Recruiting
* Myocardial Infarction; Angina Pectoris; Cerebrovascular Accidents; Diabetes Mellitus
- An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hy
ClinicalTrials.gov Identifier: NCT00449111 - Terminated
Hypertension
- ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation
ClinicalTrials.gov Identifier: NCT00296218 - Completed
Myocardial Ischemia; Hypertension
- Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice
ClinicalTrials.gov Identifier: NCT00564187 - Completed
Hypertension
- The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00185055 - Completed
Healthy
- Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00529750 - Completed
Hypertension
- Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol
ClinicalTrials.gov Identifier: NCT00549133 - Completed
Hypertension; Diabetes Mellitus Type 2
- Avoiding Cardiovascular Events through Combination therapy in patients with Systolic Hypertension ACCOMPLISH
ClinicalTrials.gov Identifier: NCT00097864 - No longer recruiting
Heart Disease
- VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-Term Hemodialysis
ClinicalTrials.gov Identifier: NCT00171080 - Completed
Hypertension
- The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension
ClinicalTrials.gov Identifier: NCT00562809 - Completed
Hypertension
- Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria
ClinicalTrials.gov Identifier: NCT00320879 - Completed
Type 2 Diabetes; Microalbuminuria
- Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
ClinicalTrials.gov Identifier: NCT00464880 - Completed
Diabetes Type 2
- Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
ClinicalTrials.gov Identifier: NCT00171561 - Completed
Hypertension
- Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
ClinicalTrials.gov Identifier: NCT00170989 - Completed
Hypertension
- Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
ClinicalTrials.gov Identifier: NCT00355589 - Completed
Hypertension; Blood Pressure, High
- Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
ClinicalTrials.gov Identifier: NCT00367094 - Completed
Hypertension
- APROVE : Irbesartan in Hypertension
ClinicalTrials.gov Identifier: NCT00283036 - Completed
Hypertension
- Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension
ClinicalTrials.gov Identifier: NCT00219037 - Completed
Hypertension
- A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00241007 - Completed
Hypertension
- Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
ClinicalTrials.gov Identifier: NCT00273299 - Completed
Hypertension
- Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)
ClinicalTrials.gov Identifier: NCT00352560 - Completed
Atrial Fibrillation
- Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.
ClinicalTrials.gov Identifier: NCT00219024 - Completed
Hypertension
- A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg
ClinicalTrials.gov Identifier: NCT00219115 - Completed
Hypertension
- Irbesartan in Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00317915 - Completed
Type 2 Diabetes; Microalbuminuria; Hypertension
- A Clinical Study to Compare Long-Term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine
ClinicalTrials.gov Identifier: NCT00294710 - Completed
Hypertension
- Treatment of High Blood Pressure Using Olmesartan with Hydrochlorothiazide Compared to an ACE Inhibitor with a Calcium Channel Blocker
ClinicalTrials.gov Identifier: NCT00185120 - Completed
Hypertension
- Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure
ClinicalTrials.gov Identifier: NCT00347087 - Completed
Chronic Heart Failure
- A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00386139 - Completed
Hypertension
- Prevention of Kidney Transplant Rejection
ClinicalTrials.gov Identifier: NCT00005010 - Completed
End-Stage Renal Disease; Chronic Allograft Nephropathy
- Olmesartan as an Add-on to Amlodipine in Hypertension
ClinicalTrials.gov Identifier: NCT00220233 - Completed
Essential Hypertension
- Using the Drug Spironolactone to test if it Reduces Protein Leakage from the Kidney
ClinicalTrials.gov Identifier: NCT00106561 - Completed
Kidney Disease; Diabetic Nephropathy; Glomerulonephritis; Proteinuria
- A Randomised, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 40 Mg Plus Hydrochlorothiazide 12.5 Mg to Telmisartan 40 Mg (Micardis®) in Patients Who Fail to Respond Adequately to Treatment with Telmisartan (Micardis®) 40 Mg
ClinicalTrials.gov Identifier: NCT00144222 - Completed
Hypertension
- Diuretics, Hypertension, and Arrhythmias Clinical Trial
ClinicalTrials.gov Identifier: NCT00000525 - Completed
Cardiovascular Diseases; Death, Sudden, Cardiac; Heart Arrest; Heart Diseases; Hypertension
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE)
ClinicalTrials.gov Identifier: NCT00243178 - Terminated
Atrial Fibrillation; Vascular Risk
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
